Delcath (DCTH) 2026 Earnings Outlook: What Investors Need
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Base value in index level serves as an anchor point for comparisons across periods, clarifying gains, losses, and scale.
23,806 articlesBiotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
Investors face a classic choice: a stalwart AI-driven CX player versus a high-growth cloud platform for financial rep...
Palantir trades at lofty multiples, but its growth engine is real. This piece weighs the high valuation against the b...
IREN is reshaping its business from crypto mining to AI data centers. This analysis dives into how the move affects i...
As AI demand reshapes chips, Intel and Arm sit at opposite ends of the risk spectrum. This analysis weighs which AI-e...
An AI-chip IPO like Cerebras can spark excitement and risk in one breath. cerebras opened $350 nearly, blasting past ...
Two cloud stock darlings sit at opposite ends of the growth vs profitability spectrum. This guide breaks down gitlab ...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Keel Infrastructure starts 2026 with a steady project backlog and disciplined financial discipline. This article tran...
Urban air mobility could redefine commuting, but investing in Joby Aviation requires weighing regulation, costs, and ...